Inflammation and Lung Cancer (Record no. 13868)

MARC details
000 -LEADER
fixed length control field 02923nam a22001697a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210521b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781493927234
International Standard Book Number 9781493927241
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Steven M. Dubinett
9 (RLIN) 10806
245 ## - TITLE STATEMENT
Title Inflammation and Lung Cancer
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York
Name of publisher, distributor, etc. Springer Science+Business Media
Date of publication, distribution, etc. 2015
300 ## - PHYSICAL DESCRIPTION
Extent 215 Pages
500 ## - GENERAL NOTE
General note Includes References and Index
520 ## - SUMMARY, ETC.
Summary, etc. The inflammatory tumor microenvironment (TME) has a multifaceted role in tumor<br/>initiation, progression, and metastasis. Whereas genetic changes are critical for the<br/>malignant transformation of epithelial cells, we now understand that components<br/>of the developing lung TME are active participants in the events precipitating lung<br/>cancer initiation and progression. Inflammation can influence the TME to orchestrate creation of a hypoxic environment, increased angiogenesis and invasion, as<br/>well as expand stem cell phenotypes.<br/>Although the origin of the inflammatory TME is an active area of investigation,<br/>two pathways have been postulated. In the intrinsic pathway, the inflammatory microenvironment is generated by genetic alterations within premalignant or neoplastic cells that lead to increased production of inflammatory mediators. Conversely, in<br/>the extrinsic pathway, the inflammatory environment is accommodating to cancer<br/>development and progression. Thus, inflammation could be present due to an unresolved infection or chronic exposure to carcinogens.<br/>A body of evidence exists at the preclinical, clinical, epidemiological, molecular,<br/>and pathological levels suggesting that inflammation is strongly associated with<br/>the development of lung cancer. Here, inflammation and lung cancer is addressed<br/>in the context of the molecular pathology of the disease as well as the relationship<br/>to chronic obstructive pulmonary disease. In addition, the important relationships<br/>between inflammation, epithelial mesenchymal transition (EMT), and lung cancer<br/>initiation and metastases are reviewed. Our understanding regarding inflammationdependent regulation of angiogenesis and eicosanoid metabolism has opened new<br/>opportunities to translate findings to clinical interventions in prevention and therapy.<br/>Finally, research in understanding the nature of inflammation and immunity in<br/>the lung cancer TME has led to ground-breaking studies applying immunotherapeutic approaches for lung cancer. The phenotype of the adaptive immune infiltrate<br/>and the diversity of cellular elements that either promote eradication of malignancy<br/>or facilitate an immunosuppressive TME favoring tumor progression are being assessed in the context of the mutational landscape of evolving and established lung<br/>cancer. These studies, reviewed here, hold promise for additional progress in controlling inflammation and leading to further improvements in immunotherapy for<br/>lung cancer.
654 ## - SUBJECT ADDED ENTRY--FACETED TOPICAL TERMS
General subdivision Oncology
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   05/21/2021   EBS3470 05/21/2021 05/21/2021 BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024